Outcomes after reversed corneal graft rejection: a report from the European VISICORT project by W John Armitage, Uwe Pleyer, Conor C Murphy, Derek Tole, Matthew D Griffin, Jesper Hjortdal, Katja C Iselin, Bertrand Vabres

Get full text

Mesenchymal stromal cell therapy compared to SGLT2-inhibitors and usual care in treating diabetic kidney disease: A cost-effectiveness analysis. by Luke E Barry, Grainne E Crealey, Paul Cockwell, Stephen J Elliman, Matthew D Griffin, Alexander P Maxwell, Timothy O'Brien, Norberto Perico, Ciaran O'Neill

Get full text

Characterization of Monogenic Kidney Disease in Older Patients With CKD by Elhussein A.E. Elhassan, Sarah Cormican, Shohdan M. Osman, Sahin Sarihan, Omri Teltsh, Fergus E. Poynton, Matthew D. Griffin, Liam Casserly, Emma McCann, Anthony J. Bleyer, Sr., Stanislav Kmoch, Martina Živná, Katherine A. Benson, Gianpiero L. Cavalleri, Peter J. Conlon

Get full text

Burden of chronic kidney disease and rapid decline in renal function among adults attending a hospital-based diabetes center in Northern Europe by Esther O'Sullivan, John Ferguson, Andrew Smyth, Fidelma P Dunne, Tomás P Griffin, Md Nahidul Islam, Matthew D Griffin, Timothy O'Brien, Damian G Griffin, Deirdre Wall, Sean F Dinneen, Paula M O'Shea, Francis M Finucane, David W Lappin, Donal N Reddan, Marcia Bell

Get full text

Senescence marker activin A is increased in human diabetic kidney disease: association with kidney function and potential implications for therapy by Hui Tang, Lilach O Lerman, Xiaohui Bian, Tomás P Griffin, Xiangyang Zhu, Md Nahidul Islam, Sabena M Conley, Alfonso Eirin, Paula M O’Shea, Allyson K Palmer, Sandra M Herrmann, Ramila A Mehta, John R Woollard, Andrew D Rule, James L Kirkland, Tamar Tchkonia, Stephen C Textor, Matthew D Griffin, LaTonya J Hickson

Get full text